In addition, our further analysis showed that the expression levels of OPN and FOXM1 were significantly upregulated in pancreatic cancer tissues and were negatively correlated with patients’ OS and DFS according to the results from TCGA data, suggesting that these two genes might be considered as alternative diagnostic and prognostic biomarkers in pancreatic cancer. This evidence concerns the gene FOXM1 and familial pancreatic carcinoma.